Degradation of Mislocalized Secretory and Membrane Proteins

错误定位的分泌和膜蛋白的选择性识别和降解已在体外重建。在这个系统中，分泌和膜蛋白的合成在其非易位的状态下，简单地通过省略ER衍生的粗糙微粒体的反应，或者，如果它们被包括在内，通过抑制易位使用cotransin。通过这些操作中的任何一种，非易位蛋白质被迅速泛素化，为它们的降解做准备。我们采用经典的分级分离和亲和纯化方法来鉴定这些非易位蛋白的选择性识别和降解机制。在过去的一年中，我们已经成功地在体外重建了许多这些事件，并使用该系统来识别因素。我们已经确定了E2酶参与，和一个关键的伴侣，促进降解。我们目前的目标是确定该途径的剩余因子，并用纯化的组分重建事件。这将为从机制上理解通路如何运作铺平道路。与此同时，我们正在进入体内系统，以了解这种降解途径在维持细胞蛋白质稳态中的重要性。

The selective recognition and degradation of mislocalized secretory and membrane proteins has been reconstituted in vitro. In this system, secretory and membrane proteins are synthesized in their non-translocated state simply by omitting ER-derived rough microsomes from the reaction or, if they are included, by inhibiting translocation using cotransin. With either of these manipulations, non-translocated proteins are rapidly ubiquitinated in preparation for their degradation. We are employing both classical fractionation and affinity purification approaches to identify the machinery for the selective recognition and degradation of these non-translocated proteins. In the past year, we have successfully reconstituted many of these events in vitro and have used this system to identify factors. We have identified the E2 enzyme involved, and a key chaperone that facilitates degradation. Our current aim is to identify the remaining factors of this pathway and reconstitute the events with purified components. This will pave the way for understanding mechanistically how the pathway operates. In parallel, we are moving into in vivo systems to understand the importance of this degradation pathway in maintaining cellular protein homeostasis.